A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

The risk for severe RSV-related outcomes was effectively reduced among children and infants who received nirsevimab in real-world clinical settings.

A group of Victorian mothers have written to the health minister after struggling to get their children an antibody nirsevimab injection as part of the state's free RSV vaccination program.When Alissa ...

The Centers for Disease Control and Prevention (CDC) recommends that pregnant women receive an RSV vaccine during their third ...

Medical experts in India are calling for urgent attention to Respiratory Syncytial Virus (RSV), a highly contagious but under-discussed cause of lower respiratory tract infections in infants ...

Medical experts are raising alarms over Respiratory Syncytial Virus (RSV), a major yet overlooked cause of serious ...

As Thailand transitions from the rainy to early winter seasons, respiratory infections surge dramatically, making awareness ...

With high hospitalisation rates during monsoon and winter, experts urge timely action, expanded access to preventive care, ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially deadly RSV.

Nearly three-quarters of infants were immunized against respiratory syncytial virus through maternal vaccination or nirsevimab during the first season those products were available, according to ...

The CDC's Advisory Committee on Immunization Practices (ACIP) has issued new vaccine recommendations affecting RSV and flu immunizations in 2025. The panel voted to expand RSV protection for infants ...